-$221.4M
Net Activity
Institutions Holding
138
Popularity Rank
#3753
Avg Weight
0.28%
Total Value
$878.0M
138 institutions currently hold INBX, with 71 net buyers and 64 net sellers this quarter.
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
64
Net Buying Institutions
71
Top 5 by Value
+$361.9M
Total Buy Value
$512.6M
Total Sell Value
71
Net Buyers
64
Net Sellers
No Form 144 planned sale filings in the last 90 days
No Schedule 13D/13G filings for this ticker
1
Filings (14d)
Inhibrx Biosciences expanded its loan agreement with Oxford Finance, increasing the total credit facility to $500 million. The company received an immediate $100 million upfront payment (Term C Loan) and can request up to an additional $225 million (Term D Loan) at the lenders' discretion. To secure the initial funding, Inhibrx issued warrants to buy roughly 21,500 shares at an exercise price of $93.21 per share.
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter